Navigation Links
Report: Community Drugstores Tied to Medication Waste
Date:5/6/2013

lations that Increase Prescription Drug Costs," warns federal and state policymakers to avoid enacting laws that undermine payers' ability to use mail-service pharmacies, preferred pharmacy networks, and other innovative pharmacy benefit management (PBM) tools. 
  • Mail-Service Pharmacies Save $46.6 Billion. Mail-service pharmacies can save Medicare seniors, employers, unions, government employee plans, consumers, and other commercial-sector payers $46.6 billion in prescription drug costs over the next ten years, according to a 2012 study.
  • National Community Pharmacists Association.  The independent drugstore lobby's own poll released earlier this year found that seniors by a 3-1 margin (51-17) agree mail-service pharmacies cost less than community drugstores.
  • The Federal Trade Commission (FTC). The FTC concluded in a 2005 report that PBM-owned mail-order pharmacies offer lower prices on prescription drugs than retail pharmacies and are very effective at capitalizing on opportunities to dispense generic medications.
  • The Journal of General Internal Medicine. In a 2011 report, the Journal of General Internal Medicine found that patients receiving their prescription medications through a mail-service pharmacy achieved better cholesterol control compared to those who obtained their statin prescriptions from their local pharmacy.
  • American Journal of Managed Care. Consumers receiving their prescription medications for chronic conditions through a mail-service pharmacy "were more likely to take them as prescribed by their doctors than did patients who
    '/>"/>

  • SOURCE Pharmaceutical Care Management Association
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4

    Related medicine technology :

    1. Pharma IQs Laboratory Informatics Report: Current Trends & Predictions for 2015
    2. Report: Independent Drugstores, Policymakers Face New Challenges
    3. Home Affairs Committees Drugs Report: Angelus Foundation Says the Prime Minister Should Not Have Rejected a Royal Commission
    4. New Report: Drugstore Networks Could Save Employers, Medicare, and Medicaid $115 Billion
    5. EpiCast Report: Cystic Fibrosis - Epidemiology Forecast to 2022
    6. Lilly Sets Date for Lilly Diabetes Pipeline Update to the Investment Community
    7. RxAlly Expands National Network With Addition Of Nineteen Community Pharmacy Organizations Representing Over 2,000 Pharmacies
    8. GHX Reveals Roadmap to Stronger Healthcare Community at GHX Healthcare Supply Chain Summit
    9. UCB Proudly Reinforces Long-Standing Commitment to Crohns Disease Community at Digestive Disease Week 2012
    10. CBIs Access World Combines 3 Events for 3 Days of Content, Connections, Community
    11. Community Pharmacists Take on Medication Non-Adherence to Improve Patient Health
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:1/23/2015)... /PRNewswire/-- Harwood Feffer LLP ( www.hfesq.com ) is investigating potential ... ("Advaxis" or the "Company") (NASDAQ: ADXS ), ... to shareholders. On January 21, 2015, an ... Advaxis had misrepresented the clinical data for its ADXS-HPV ...
    (Date:1/23/2015)... Biotechnology Holdings, Inc. (OTCQB: LIXT), announced that the number of ... compound, LB‑100, is being conducted, has been expanded from 1 ... M.D., the founder and President of Lixte, said that, "the ... site. Accrual of patients, however, was slower than projected. The ...
    (Date:1/23/2015)... Ala. , Jan. 23, 2015 Gem Pharmaceuticals ... patients have been enrolled into the Company,s Phase 2 ... and safety of Gem,s lead compound, GPX-150 (an investigational ... advanced or metastatic disease. Logo - ...
    Breaking Medicine Technology:Harwood Feffer LLP Announces Investigation of Advaxis, Inc. 2Lixte Biotechnology Holdings Announces Expansion Of Clinical Sites For Its Phase I Trial Of Its Lead Anti-Cancer Compound, LB-100 2Lixte Biotechnology Holdings Announces Expansion Of Clinical Sites For Its Phase I Trial Of Its Lead Anti-Cancer Compound, LB-100 3Gem Pharmaceuticals Announces Enrollment of Initial Patients in its Phase 2 Clinical Trial to Assess the Efficacy and Safety of GPX-150 in Sarcoma Patients 2
    (Date:1/22/2015)... VogueQueen is a seasoned and trusted leader who ... are thrilled to have it lead the wedding dress industry ... of prom dresses for the global market. , “The CEO ... and he focuses on continuing the goal of operational excellence ...
    (Date:1/22/2015)... 22, 2015 The federal court overseeing thousands ... District Court, Southern District of West Virginia has upheld a ... proceeding’s first bellwether trial. In an Order dated January 21st, ... after finding that C.R. Bard had not proven a miscarriage ...
    (Date:1/22/2015)... January 22, 2015 For over 20 years, Dr. ... Oceanside and Vista area has treated just about every type ... injury circumstances. And for those same twenty-plus years, the team ... all those injuries with the best possible doctor. With ...
    (Date:1/22/2015)... has added many trendy Champagne wedding dresses to ... the past three years. Today, the business announces a special ... the sales manager of the company, this is on the ... point can be reflected on the discounted wedding dresses from ...
    (Date:1/22/2015)... January 22, 2015 As interest in the ... care gains momentum worldwide, Rev. Eric J. Hall , ... Network (HCCN), will be the keynote speaker on January ... Israel’s public health system. , The conference, “Hope and Resilience: ...
    Breaking Medicine News(10 mins):Health News:VogueQueen Unveils New Designs of Prom Dresses for 2015 2Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 2Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 3Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 4Health News:Industry Leading Chiropractor in Oceanside Joins the Doctors on Liens Network 2Health News:Weddingshe Announces A Special Offer On Its Popular Glamorous Wedding Dresses 2Health News:HealthCare Chaplaincy CEO to Keynote Spiritual Care Summit in Israel 2Health News:HealthCare Chaplaincy CEO to Keynote Spiritual Care Summit in Israel 3
    ... NEW YORK, Sept. 28 Small Bone Innovations,Inc. ... education,for the small bone and joint orthopedic market ... Radial Head Implant System. To further,augment its Elbow ... System for internal fixation of proximal radius,fractures. ...
    ... Admission for All Children on October 6th, CAMBRIDGE, ... division of Shire plc, the global specialty,biopharmaceutical company, invites ... Museum on Saturday, October 6th for,"Shire Day" when all ... be granted,free admission. As part of the day, all ...
    ... directed health plan (CDHP) offerings are more engaged ... and save for healthcare,expenses than those in traditional ... by the Blue Cross and Blue Shield,Association (BCBSA). ... found that consumers,eligible for health savings accounts (HSAs) ...
    ... of a particular lung tumor can help clinicians make ... first. , A new study led by researchers from ... Institute for Genome Sciences & Policy (IGSP) found distinct ... used chemotherapy drugs. , We were able to ...
    ... Transcept,Pharmaceuticals, Inc., a specialty pharmaceutical company deriving,significant ... announced,that Glenn A. Oclassen, President and Chief Executive ... Investor Forum at the Palace Hotel in San,Francisco ... Pacific Time. About Transcept Pharmaceuticals Transcept ...
    ... - Renowned physicians provide viewers with important information on the use, ... ... strokes -, SILVER SPRING, Md., ... its use in the primary and,secondary prevention of cardiovascular and cerebral-vascular events.,Premiering ...
    Cached Medicine News:Health News:SBi Launches rHead(TM) Lateral Radial Head Implant and rHead(TM) Plating Systems to Expand its Elbow Management System 2Health News:SBi Launches rHead(TM) Lateral Radial Head Implant and rHead(TM) Plating Systems to Expand its Elbow Management System 3Health News:SBi Launches rHead(TM) Lateral Radial Head Implant and rHead(TM) Plating Systems to Expand its Elbow Management System 4Health News:Families Invited to Celebrate 'Shire Day' at Boston Children's Museum 2Health News:Blue Cross And Blue Shield Association Survey Shows Consumer Driven Health Plan Enrollees Are Taking More Control of Their Healthcare 2Health News:Blue Cross And Blue Shield Association Survey Shows Consumer Driven Health Plan Enrollees Are Taking More Control of Their Healthcare 3Health News:Genomic profiling of lung tumors helps doctors choose most effective treatment 2Health News:Genomic profiling of lung tumors helps doctors choose most effective treatment 3Health News:Discovery Health CME Explores the Benefits and Risks of Aspirin in Aspirin Therapy: Maximizing the Benefits 2Health News:Discovery Health CME Explores the Benefits and Risks of Aspirin in Aspirin Therapy: Maximizing the Benefits 3Health News:Discovery Health CME Explores the Benefits and Risks of Aspirin in Aspirin Therapy: Maximizing the Benefits 4
    ... Colorimetric Assay ... (UH) and Low ... (LMWH).Chromogenic substrate CBS ... freeze-dried; purified bovine ...
    Colorimetric Assay of Unfractionated and Low Molecular Weight Heparins by STA© Analyzers. Lyophilized, patent-pending chromogenic substate, CBS 52.44 of ~4.2 moles/vial and bovine factor Xa ~1.1...
    Substrate Plasma for Factor V Assay by STA© Analyzers. Freeze-dried human plasma, artificially depleted of factor V....
    Substrate Plasma for Factor X Assay by STA© Analyzers. Freeze-dried human plasma from which factor X has been removed by selective immuno-adsorption....
    Medicine Products: